DIN 02518244 — KANJINTI 150 MG
KANJINTI is a powder for solution of Trastuzumab marketed by AMGEN CANADA INC. The full Trastuzumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02518244
- Brand name
- KANJINTI
- Active ingredient
- Trastuzumab
- Strength
- 150 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic (HER2-targeted monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Trastuzumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02240692 | HERCEPTIN | 440 MG | POWDER FOR SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02480697 | HERCEPTIN SC | 600 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02506211 | HERZUMA | 150 MG | POWDER FOR SOLUTION | CELLTRION INC. | MARKETED |
| 02480794 | HERZUMA | 440 MG | KIT; POWDER FOR SOLUTION | CELLTRION INC. | MARKETED |
| 02496690 | KANJINTI | 420 MG | KIT; POWDER FOR SOLUTION | AMGEN CANADA INC | MARKETED |
| 02474425 | OGIVRI | 150 MG | POWDER FOR SOLUTION | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | MARKETED |
| 02524317 | ONTRUZANT | 150 MG | POWDER FOR SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02524325 | ONTRUZANT | 440 MG | POWDER FOR SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02483475 | TRAZIMERA | 150 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02483467 | TRAZIMERA | 440 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED |